Cargando…
In Brief: Myeloid‐derived suppressor cells in cancer
The role of myeloid‐derived suppressor cells (MDSCs) in cancer development has become clear over recent years, and MDSC targeting is an emerging opportunity for enhancing the effectiveness of current anticancer therapies. As MDSCs are not only able to limit anti‐tumour T‐cell responses, but also to...
Autores principales: | Solito, S, Pinton, L, Mandruzzato, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413806/ https://www.ncbi.nlm.nih.gov/pubmed/28097660 http://dx.doi.org/10.1002/path.4876 |
Ejemplares similares
-
Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
por: Damuzzo, Vera, et al.
Publicado: (2015) -
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
por: Pinton, Laura, et al.
Publicado: (2015) -
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs)
por: Mazza, Emilia Maria Cristina, et al.
Publicado: (2014) -
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
por: Trovato, Rosalinda, et al.
Publicado: (2019) -
Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia
por: Ahn, Ari, et al.
Publicado: (2021)